| Literature DB >> 28656073 |
David B Bartlett1,2, Sam O Shepherd3, Oliver J Wilson4, Ahmed M Adlan5, Anton J M Wagenmakers3, Christopher S Shaw6, Janet M Lord1.
Abstract
Neutrophils and monocytes are key components of the innate immune system that undergo age-associated declines in function. This study compared the impact of high-intensity interval training (HIIT) and moderate-intensity continuous training (MICT) on immune function in sedentary adults. Twenty-seven (43 ± 11 years) healthy sedentary adults were randomized into ten weeks of either a HIIT (>90% maximum heart rate) or MICT (70% maximum heart rate) group training program. Aerobic capacity (VO2peak), neutrophil and monocyte bacterial phagocytosis and oxidative burst, cell surface receptor expression, and systemic inflammation were measured before and after the training. Total exercise time commitment was 57% less for HIIT compared to that for MICT while both significantly improved VO2peak similarly. Neutrophil phagocytosis and oxidative burst and monocyte phagocytosis and percentage of monocytes producing an oxidative burst were improved by training similarly in both groups. Expression of monocyte but not neutrophil CD16, TLR2, and TLR4 was reduced by training similarly in both groups. No differences in systemic inflammation were observed for training; however, leptin was reduced in the MICT group only. With similar immune-enhancing effects for HIIT compared to those for MICT at 50% of the time commitment, our results support HIIT as a time efficient exercise option to improve neutrophil and monocyte function.Entities:
Mesh:
Year: 2017 PMID: 28656073 PMCID: PMC5471589 DOI: 10.1155/2017/8148742
Source DB: PubMed Journal: Oxid Med Cell Longev ISSN: 1942-0994 Impact factor: 6.543
Group baseline and final values for participant body composition and fitness measures.
| HIIT | MICT | |||
|---|---|---|---|---|
| Baseline | Final | Baseline | Final | |
|
| 14 (4/10) | 13 (5/8) | ||
| Age (years) | 42 (12) | 45 (10) | ||
| Body composition | ||||
| Height (cm) | 167 (7) | 166 (9) | ||
| Body mass (kg) | 78.1 (19.9) | 77.7 (19.4) | 79.0 (15.2) | 78.4 (16.2) |
| BMI (kg/m2) | 28.1 (6.1) | 27.9 (6.0) | 28.1 (4.7) | 27.9 (5.0) |
| Fat mass (%) | 32.9 (8.2) | 31.8 (8.2) | 32.2 (8.6) | 30.9 (8.7)∗ |
| Physical fitness | ||||
| VO2max (L min−1) | 2.4 (0.6) | 2.7 (0.7)∗∗∗ | 2.6 (0.6) | 2.9 (0.7)∗∗∗ |
| VO2max (mL/kg min−1) | 31.5 (6.4) | 35.0 (8.4)∗∗∗ | 32.6 (5.8) | 35.8 (7.1)∗∗∗ |
BMI: body mass index. Data are mean (SD) unless otherwise stated. ∗p < 0.05, ∗∗∗p < 0.001 are significant within group change scores.
Group baseline and final values for neutrophil and monocyte phagocytosis of E. coli and oxidative burst towards E. coli.
| HIT | MICT | |||
|---|---|---|---|---|
| Baseline | Final | Baseline | Final | |
| Neutrophil | ||||
| Phagocytosis (MFI) | 130.6 (16.6) | 152 (17.2)∗ | 126.2 (12.5) | 145.5 (14.1)∗ |
| Oxidative burst (MFI) | 69.0 (24.5) | 74.6 (22.1)∗ | 77.6 (18.2) | 104.8 (16.5)∗∗ |
| Monocyte | ||||
| Phagocytosis (MFI) | 99.3 (10.4) | 113.3 (11.6)∗∗ | 92.9 (12.2) | 110.4 (13.8)∗∗ |
| Oxidative burst (MFI) | 27.5 (8.4) | 22.7 (9.1) | 30.9 (11.7) | 27.8 (13.5) |
| Oxidative burst (%) | 74.4 (10.0) | 81.6 (11.1)∗ | 74.4 (13.7) | 85.6 (12.1)∗∗ |
MFI: median fluorescence intensity. Data are mean (SD). ∗p < 0.05 and ∗∗p < 0.01 are significant within group change scores.
Figure 1Final minus baseline change scores for group immune function. HIIT was comparable to MICT for changes in neutrophil phagocytosis (a), neutrophil superoxide (b), monocyte phagocytosis (c), monocyte superoxide (d), and percentage of monocytes-producing superoxide (e). N.S.—nonsignificant differences between groups.
Group baseline and final values for total numbers of white blood cells, percentages of monocyte subsets, and expression of TLR4 and TLR2.
| HIIT | MICT | |||
|---|---|---|---|---|
| Baseline | Final | Baseline | Final | |
| Total WBC (×109 L−1) | 7.4 (2.7) | 8.2 (2.1) | 8.2 (1.1) | 7.7 (2.4) |
| Lymphocytes (×109 L−1) | 2.4 (0.9) | 2.5 (0.7) | 2.5 (0.4) | 2.7 (0.5) |
| Neutrophils (×109 L−1) | 4.6 (1.8) | 5.2 (1.7) | 5.2 (1.2) | 4.4 (2.0) |
| Monocytes (×109 L−1) | 0.3 (0.2) | 0.4 (0.2) | 0.4 (0.2) | 0.5 (1.1) |
| CD14+/CD16− (%) | 87.2 (4.7) | 91.1 (4.5)∗∗ | 86.9 (5.8) | 89.8 (6.1)∗ |
| TLR4 (MFI) | 3.9 (1.2) | 3.8 (1.4) | 3.9 (1.2) | 3.8 (1.3) |
| TLR2 (MFI) | 119 (11.2) | 120 (10.1) | 121 (13.4) | 123 (14.1) |
| CD14+/CD16int (%) | 4.4 (2.8) | 3.1 (2.2)∗ | 4.7 (2.4) | 3.6 (2.2)∗ |
| TLR4 (MFI) | 5.0 (2.1) | 4.9 (2.8) | 5.1 (2.0) | 4.9 (2.1) |
| TLR2 (MFI) | 123 (15.3) | 116 (16.5)∗ | 124 (18.9) | 119 (19.9)∗ |
| CD14+/CD16bright (%) | 8.1 (4.4) | 5.8 (3.9)∗ | 8.4 (3.1) | 6.9 (4.2) |
| TLR4 (MFI) | 4.6 (3.2) | 4.0 (2.7)∗∗ | 4.5 (3.0) | 3.9 (2.7)∗∗ |
| TLR2 (MFI) | 86 (10.9) | 85 (12.6) | 91 (13.2) | 93 (14.0) |
WBC: white blood cell; CD: cluster of differentiation; TLR: toll-like receptor; MFI: median fluorescence intensity. Data are mean (SD). ∗p < 0.05 and ∗∗p < 0.01 are significant within group change scores.
Group baseline and final values for inflammatory cytokines and acute phase proteins, endocrine, and metabolic hormones.
| HIIT | MICT | |||
|---|---|---|---|---|
| Baseline | Final | Baseline | Final | |
| Proinflammatory | ||||
| IL-1 | 0.1 (0.08) | 0.1 (0.1) | 0.5 (1.2) | 0.4 (0.9) |
| IL-6 (pg mL−1)a | 1.4 (1.6) | 1.0 (1.0) | 1.2 (1.0) | 0.8 (0.8) |
| IL-8 (pg mL−1) | 5.7 (2.1) | 4.4 (1.5) | 5.7 (2.5) | 5.4 (2.3) |
| IL-17 (pg mL−1)a | 5.5 (17.9) | 5.2 (15.7) | 13.8 (23.4) | 5.5 (14.7) |
| TNF | 0.8 (2.1) | 0.1 (0.4) | ND | 0.2 (0.5) |
| CRP (mg L−1)a | 3.0 (4.3) | 2.1 (2.2) | 1.2 (1.4) | 1.6 (1.8) |
| GM-CSF (pg mL −1)a | 0.02 (0.06) | ND | 0.02 (0.07) | 0.02 (0.07) |
| Anti-inflammatory | ||||
| IL-4 (pg mL−1)a | 0.04 (0.1) | 0.06 (0.1) | 0.02 (0.05) | 0.05 (0.07) |
| IL-10 (pg mL−1)a | 0.3 (1.1) | ND | ND | ND |
| IL-13 (pg mL−1)a | 0.7 (1.2) | 0.6 (0.9) | 1.1 (1.8) | 0.7 (1.1) |
| Endocrine | ||||
| Cortisol (nmol L−1)a | 200 (61.3) | 190 (62.1) | 197 (98.6) | 183 (56.0) |
| DHEAs (nmol L−1) | 3563 (1965) | 3841 (2087) | 4464 (2335) | 4144 (1739) |
| Cortisol: DHEAs | 0.07 (0.03) | 0.06 (0.04) | 0.05 (0.03) | 0.05 (0.02) |
| Metabolic | ||||
| Adiponectin ( | 3.8 (1.9) | 3.6 (1.8) | 3.3 (1.2) | 3.1 (1.3) |
| Leptin (ng mL−1) | 19.3 (11.3) | 18.0 (10.8) | 16.4 (9.6) | 14.6 (10.2)∗ |
| Leptin: adiponectin | 6.0 (4.4) | 6.1 (4.3) | 6.0 (4.6) | 5.8 (5.3) |
IL: interleukin; TNF: tumour necrosis factor; ND: nondetectable; CRP: high sensitivity C-reactive protein; GM-CSF: granulocyte/macrophage colony-stimulating factor; DHEAs: dehydroepiandrosterone sulphate. Data are mean (SD). aNot normally distributed and were log transformed. ∗p < 0.05 significant within group change scores.